Tuberculosis, Pulmonary Clinical Trials

16 recruiting

Tuberculosis, Pulmonary Trials at a Glance

16 actively recruiting trials for tuberculosis, pulmonary are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Phase 3 with 5 trials, with the heaviest enrollment activity in Kampala, Bobigny, and Busan. Lead sponsors running tuberculosis, pulmonary studies include Johns Hopkins University, Eleonora Nucera, and Children's Hospital Medical Center, Cincinnati.

Browse tuberculosis, pulmonary trials by phase

Treatments under study

About Tuberculosis, Pulmonary Clinical Trials

Looking for clinical trials for Tuberculosis, Pulmonary? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tuberculosis, Pulmonary trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tuberculosis, Pulmonary clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting

Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment

Tuberculosis, PulmonaryMycobacterium TuberculosisTuberculosis, Extra-Pulmonary
University of Oxford140 enrolled1 locationNCT06845618
Recruiting
Phase 3

Shortened Regimen for Drug-susceptible TB in Children

TuberculosisTuberculosis, PulmonaryMycobacterium Tuberculosis+1 more
Johns Hopkins University860 enrolled9 locationsNCT06253715
Recruiting

18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

Tuberculosis, Pulmonary
Children's Hospital Medical Center, Cincinnati30 enrolled1 locationNCT07077213
Recruiting
Not Applicable

Clinic-based Versus Hotspot-focused Active TB Case Finding

Tuberculosis, PulmonaryMycobacterium Tuberculosis Infection
Johns Hopkins University150,000 enrolled1 locationNCT05285202
Recruiting
Phase 3

Pragmatic Optimized Rifampicin Trial

Tuberculosis, Pulmonary
Radboud University Medical Center164 enrolled2 locationsNCT06057519
Recruiting
Phase 2Phase 3

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco400 enrolled6 locationsNCT06441006
Recruiting
Not Applicable

Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting

Tuberculosis, Pulmonary
Indonesia University58 enrolled1 locationNCT07271225
Recruiting

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

Tuberculosis, Pulmonary
Karolinska Institutet30 enrolled2 locationsNCT06585358
Recruiting
Phase 1

ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74

Tuberculosis, Pulmonary
Quratis Inc.144 enrolled4 locationsNCT06714513
Recruiting
Phase 2

Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline

Tuberculosis, Pulmonary
Makerere University200 enrolled2 locationsNCT06477185
Recruiting

A Systemic Screening for TB Disease in High-risk Groups in Barcelona

TuberculosisTuberculosis, Pulmonary
Fundació Institut Germans Trias i Pujol3,000 enrolled1 locationNCT06706596
Recruiting
Phase 2Phase 3

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

Tuberculosis, Pulmonary
University of Cape Town220 enrolled1 locationNCT04147286
Recruiting
Not Applicable

Conventional Bronchoscope With BAL vs. Thin Bronchoscope With BW to Diagnose Pulmonary TB

Tuberculosis, Pulmonary
Pusan National University Hospital132 enrolled1 locationNCT06159023
Recruiting

Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students

TuberculosisTuberculosis, PulmonaryTuberculosis Infection+2 more
Eleonora Nucera2,040 enrolled1 locationNCT05756582
Recruiting
Phase 2Phase 3

Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

Tuberculosis, Pulmonary
Huashan Hospital2,442 enrolled6 locationsNCT05401071
Recruiting

Tuberculosis Cohort Avicenne Hospital

Tuberculosis, Pulmonary
Assistance Publique - Hôpitaux de Paris250 enrolled2 locationsNCT05539014